Reporter plasmid carring TCF-binding consensus sequence.
![]() Drawn by SnapGene® software |
|
| Clone info. | Reporter plasmid carring 7 repeates of the TCF-binding consensus sequence upstream of the IFN-beta basal promoter followed by the luciferase geme. p55Bluc was made by inserting the minimam promoter sequences of human IFNbeta gene into the MCS of PGV-B (TOYO B-Net CO., LTD). Expression was confirmed by depositor as follows: reporter assay. |
|---|---|
| Comment | Use pTcf7mtluc (RDB02969) as a negative control. |
| Vector backbone | p55Bluc (Plasmid) |
| Size of vector backbone | 5,700 bp |
| Selectable markers | Amp^r |
| Growth conditions | 37 C, LB+Amp |
| Gene/insert name | firefly (Photinus pyralis) luciferase cDNA |
| Depositor|Developer | Shimotohno, Kunitada | |
Please check terms and conditions set forth by the depositor, which are specified in the RIKEN BRC Catalog and/or Web Catalog.
| Ordering forms | Order form [Credit Card Payment MTA, for use for not-for-profit academic purpose [Word MTA, for use for for-profit purpose [Word Please visit Information of Request for Distribution.[link] |
|---|---|
| Terms and conditions for distribution | The research materials will be provided to both non-profit and for-profit organizations. In publishing the research results obtained by use of the BIOLOGICAL RESOURCE, an acknowledgment to DEPOSITOR and a citation of the literature designated by the DEPOSITOR are requested. (Ueda, Y. et al., Int. J. Cancer, 99 (5):681-688, 2002) |
[open/close]| 必要書類 | 提供依頼書 提供同意書 (MTA, 非営利学術目的用)[Word 提供同意書 (MTA, 営利目的用)[Word 手続きの概要は、「提供申込みについて[link]」をご覧ください。 |
|---|---|
| MTAに書く使用条件 | 本件研究材料は、非営利機関及び営利機関の区別なく提供する。利用者は、研究成果の公表にあたって寄託者への謝辞の表明を必要とし、寄託者の指定する文献を引用すること(Ueda, Y. et al., Int. J. Cancer, 99 (5):681-688, 2002)。 |
| Catalog # | Resource name | Shipping form | Fee |
|---|---|---|---|
| RDB02968 | pTcf7wtluc | DNA solution | Please contact us. |
Materials & Methods section:
| The pTcf7wtluc was provided by the RIKEN BRC through the National BioResource Project of the MEXT, Japan (cat. RDB02968). |
Reference section:
| Ueda, Y., Hijikata, M., Takagi, S., Takada, R., Takada, S., Chiba, T., Shimotohno, K., Wnt/beta-catenin signaling suppresses apoptosis in low serum medium and induces morphologic change in rodent fibroblasts. Int. J. Cancer, 99 (5): 681-688 (2002). PMID 12115501. [PubMed] [Article] [RRC of NBRP] |
Further references such as user reports and related articles (go to bottom)
Original, user report and related articles
| original | Ueda, Y., Wnt/beta-catenin signaling suppresses apoptosis in low serum medium and induces morphologic change in rodent fibroblasts. Int. J. Cancer, 99 (5): 681-688 (2002). PMID 12115501. [PubMed] [Article] [RRC of NBRP] |
|---|---|
| user_report | Kwon, Y.J., Basroparib overcomes acquired resistance to MEK inhibitors by inhibiting Wnt-mediated cancer stemness in KRAS-mutated colorectal cancer. Biochem. Pharmacol. 235: 116842 (2025). PMID 40024348. [PubMed] [Article] [RRC of NBRP] |
| user_report | Tanaka, N., APC Mutations as a Potential Biomarker for Sensitivity to Tankyrase Inhibitors in Colorectal Cancer. Mol. Cancer Ther. 16 (4): 752-762 (2017). PMID 28179481. [PubMed] [Article] [RRC of NBRP] |
Featured content